Hospital for Special Surgery has partnered with General Atlantic to create a new national platform for expanding outpatient orthopedic and spine care through the acquisition of Legent Health.

Target Information

The Hospital for Special Surgery (HSS), renowned as the nation's leading orthopedic hospital, is collaborating with General Atlantic, a prominent global investment firm, to establish a new national platform of independently operated ambulatory surgery centers (ASCs). This initiative aims to enhance patient access to advanced, patient-centered outpatient care in orthopedic and spine specialties. The collaboration also includes the acquisition of Legent Health, a well-regarded operator of orthopedic and spine facilities, creating a solid foundation for scaling operations.

This new platform is a substantial advancement toward meeting the growing need for specialized orthopedic and spine care across the nation. It combines the expertise of HSS, which boasts a vast network of over 1,750 alumni surgeons, with General Atlantic's extensive experience in building and managing physician-align healthcare platforms, thus ensuring a comprehensive approach to care.

Industry Overview

The orthopedic and spine care sector is witnessing a dramatic transformation, with a significant shift from traditional hospital settings to outpatient environments. Increased patient demand for advanced surgical solutions has necessitated the need for more accessible and cost-effective care options. Ambulatory surgery centers have proven to be an efficient alternative, allowing procedures that once required extensive hospital stays to be performed safely and effectively.

In recent years, the orthopedic industry has evolved, emphasizing the importance of patient-centered care that prioritizes comfort, accessibility, and outcomes. This shift has been accelerated by technological advancements and a broader understanding of patient needs and preferences in treatment, driving growth in the outpatient surgical landscape.

The United States is at the forefront of this evolution, where the integration of innovative surgical practices within ASCs is receiving heightened attention. These centers not only provide enhanced operational efficiencies but also contribute to improved patient experiences and outcomes. As more healthcare providers recognize the benefits of outpatient procedures, industries related to musculoskeletal health are poised for significant growth driven by convenience and patient satisfaction.

By expanding the availability of outpatient care options, the orthopedic and spine sector addresses the imbalance between the supply of specialized care and rising patient demand. The potential for growth is substantial, particularly in underserved areas where access to specialized orthopedic services can be limited.

Rationale Behind the Deal

The collaboration between HSS and General Atlantic brings together critical resources and expertise aimed at transforming the delivery of orthopedic and spine outpatient care across the United States. This strategic alliance is designed to meet the increasing demand for specialized care while ensuring high standards of quality and safety.

By leveraging the established operational framework of Legent, the new platform aims to introduce advanced care options closer to patients' homes, offering lower-cost services with enhanced outcomes. Moreover, this venture will create strong partnerships with surgeons and health systems that foster alignment and engagement through equity participation and clinical autonomy.

Information about the Investor

General Atlantic has a well-established reputation as a leading global investor, with over 40 years of experience in providing capital and forward-thinking strategic support to a diverse range of companies. Founded in 1980, the firm focuses on partnering with visionary entrepreneurs, leveraging its deep sector expertise to facilitate sustainable growth and create long-term value across various industries.

With approximately $114 billion in assets under management, General Atlantic operates in crucial areas including Growth Equity, Credit, Climate, and Sustainable Infrastructure strategies. The firm’s commitment to building community-based health platforms underscores its forward-looking approach to investing in high-potential sectors, including healthcare and outpatient services.

View of Dealert

This partnership between HSS and General Atlantic represents a prudent investment opportunity that capitalizes on the growing trend toward outpatient care in orthopedics and spine health. As procedures increasingly migrate from hospital settings to ASCs, the demand for high-quality outpatient care is likely to continue soaring. HSS's stellar reputation and extensive experience provide a strong foundation for this new venture, ensuring that quality standards remain paramount, while General Atlantic's strategic expertise facilitates scalable growth.

Furthermore, the collaboration's focus on providing affordable and accessible care will address a significant market need, particularly in communities where specialized orthopedic services are scarce. The potential to forge partnerships with local health systems and engage surgeons through shared equity programs can enhance alignment and foster a sense of ownership in the care delivery process.

As the platform expands nationally, it will likely benefit from economies of scale and a growing patient base, ultimately enhancing profitability. This investment aligns well with current market trends, positioning the platform for success in enhancing patient access to exceptional orthopedic and spine care.

Overall, this venture signifies a strategic approach to meet increasing patient demand, fundamentally improving patient access and satisfaction in the orthopedic and spine care landscape. The partnership is well-positioned to adapt to the evolving healthcare landscape, making it a promising investment in the current market environment.

View Original Article

Hospital for Special Surgery and General Atlantic

invested in

Legent Health

in 2025

in a Buyout deal

Deal Parametres
Industry
Country
Seller type

Sign Up to Dealert